Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 18/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3301370 | 0.90 | MAPT (0.48) | NAMPTMAPTALDH1A1LMNAGAA | |
| SCHEMBL3301281 | 0.89 | MEN1 (0.47) | NAMPTMAPTALDH1A1LMNARXFP1 | |
| SCHEMBL3296270 | 0.85 | MAPT (0.47) | NAMPTCA2MAPTALDH1A1LMNA | |
| SCHEMBL3306730 | 0.84 | MAPT (0.47) | CA2MAPTALDH1A1LMNARXFP1 | |
| SCHEMBL3302587 | 0.81 | MAPT (0.46) | NAMPTCA2MAPTALDH1A1LMNA | |
| SCHEMBL3304673 | 0.81 | MAPT (0.47) | NAMPTMAPTALDH1A1LMNAGAA | |
| SCHEMBL3301325 | 0.81 | MAPT (0.45) | NAMPTCA2MAPTALDH1A1LMNA | |
| SCHEMBL3582698 | 0.81 | IKBKB (0.55) | — | |
| SCHEMBL3295573 | 0.80 | IKBKB (0.44) | CA2MAPTALDH1A1RXFP1 | |
| SCHEMBL3300127 | 0.80 | MAPT (0.44) | CA2MAPTLMNARXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009056693-A1 | NOVEL DERIVATIVES OF N, N'- 2, 4-DIANILINOPYRIMIDINES, PREPARATION THEREOF AS MEDICAMENTS PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS IKK INHIBITORS | SANOFI-AVENTIS (FR) | 2009-05-07 | — | — | WO | disclosed |